Changeflow GovPing Healthcare & Life Sciences USPTO Patent Grant: Kit for Producing and Stori...
Routine Notice Added Final

USPTO Patent Grant: Kit for Producing and Storing Radiopharmaceuticals

Favicon for changeflow.com USPTO Patent Grants - Therapeutics (A61P)
Published
Detected
Email

Summary

The USPTO has granted patent US12582729B2 to Wake Forest University Health Sciences for a kit technology designed for the production and long-term storage of Zr-89-PET radiopharmaceuticals. The patent covers improved stability for radiopharmaceuticals and a method for their production.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582729B2, titled 'Kit for producing and storing radiopharmaceuticals,' to Wake Forest University Health Sciences. The patent, filed on January 25, 2019, and granted on March 24, 2026, relates to radiopharmaceuticals with improved stability, specifically a kit and method for producing Zr-89-PET radiopharmaceuticals. This grant signifies the USPTO's recognition of novel technology in the field of radiopharmaceutical production and storage.

This patent grant is primarily an informational event for the pharmaceutical and healthcare sectors. While it does not impose new regulatory obligations or compliance deadlines on entities, it highlights advancements in radiopharmaceutical technology. Companies involved in the development, manufacturing, or clinical use of PET radiopharmaceuticals, particularly those utilizing Zr-89, should be aware of this patented technology. It may influence future research, development, and commercialization strategies in this specialized area of medical imaging and therapy.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Kit technology for the production and long-term storage of Zr-89-PET radiopharmaceuticals

Grant US12582729B2 Kind: B2 Mar 24, 2026

Assignee

WAKE FOREST UNIVERSITY HEALTH SCIENCES

Inventors

Thaddeus J. Wadas, Nikunj B. Bhatt, Darpan N. Pandya

Abstract

The present invention is directed to radiopharmaceuticals with improved stability, a kit, and a method of production thereof.

CPC Classifications

A61K 51/0478 A61K 45/06 A61K 51/1093 A61K 51/121 A61K 47/183 A61K 31/198 A61K 2300/00 C07K 16/2863 C07K 16/32 C07K 2317/24 A61P 35/00

Filing Date

2019-01-25

Application No.

16964377

Claims

14

View original document →

Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582729B2

Who this affects

Applies to
Drug manufacturers Medical device makers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 6211 Healthcare Providers
Activity scope
Drug Manufacturing Radiopharmaceutical Production
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!